US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Rexahn Pharmaceuticals

1.81

0.0000

Volume:- -

Turnover:- -

Market Cap:2.00M

PE:-0.29

High:1.81

Open:1.81

Low:1.81

Close:1.81

52wk High:17.04

52wk Low:1.81

Shares:1.11M

Float Shares:1.10M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-6.2533

EPS(LYR):-8.7223

ROE:-72.93%

ROA:-33.73%

PB:0.35

PE(LYR):-0.21

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Rexahn Pharmaceuticals

Exchange:

NASDAQ

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

http://www.rexahn.com

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of cancer. The company's product pipeline include RX-3117, which is in Phase IIa clinical trials for the treatment of patients with relapsed or refractory metastatic pancreatic cancer, as well as bladder, colon, lung and cervical cancer. It is also developing RX-0301, which is in preclinical development stage for the treatment of hepatocellular carcinoma. Rexahn Pharmaceuticals, Inc. has collaboration agreements with Zhejiang Haichang Biotechnology Co., Ltd.; and BioSense Global LLC. The company is headquartered in Rockville, Maryland.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/REXN/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"REXN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"REXN\",,,,,undefined,":{"symbol":"REXN","market":"US","secType":"STK","nameCN":"Rexahn Pharmaceuticals","latestPrice":1.81,"timestamp":1604610000000,"preClose":1.81,"halted":8,"volume":0,"delay":0,"changeRate":0,"floatShares":1104270,"shares":1106754,"eps":-6.25332,"marketStatus":"Post-Mkt","change":0,"latestTime":"02-24 16:14:15 EST","open":1.81,"high":1.81,"low":1.81,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-6.25332,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1771981200000},"marketStatusCode":4,"symbolChange":{"newSymbol":"OCUP","executeDate":"2020-11-06"},"adr":0,"listingDate":1100235600000,"exchange":"NASDAQ","adjPreClose":1.81,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"REXN\",,,,,undefined,":{"symbol":"REXN","floatShares":1104270,"roa":"-33.73%","roe":"-72.93%","lyrEps":-8.7223,"shares":1106754,"dividePrice":0,"high":1.81,"amplitude":0,"preClose":1.81,"low":1.81,"week52Low":1.81,"pbRate":"0.35","week52High":17.04,"institutionHeld":0,"latestPrice":1.81,"eps":-6.25332,"divideRate":0,"volume":0,"delay":0,"ttmEps":-6.25332,"open":1.81},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/REXN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2020-11-06","symbol":"REXN","defaultRemindTime":1604673000000,"type":"split","dateTimestamp":1604638800000,"forFactor":4,"toFactor":1,"ratio":4},{"market":"US","date":"2020-11-06","symbol":"REXN","oldSymbol":"REXN","defaultRemindTime":1604673000000,"newSymbol":"OCUP","exchange":"NASDAQ","type":"symbolChange","dateTimestamp":1604638800000},{"date":"2020-11-04","symbol":"REXN","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":"2020/09","expectedEps":null,"defaultRemindTime":1604480400000,"name":null,"time":"","dateTimestamp":1604466000000,"actualEps":null},{"market":"US","date":"2020-05-07","symbol":"REXN","fiscalQuarterEnding":"2020/03","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1588824000000,"reportTimeType":"","actualEps":-0.15},{"market":"US","date":"2019-11-06","symbol":"REXN","fiscalQuarterEnding":"2019/09","expectedEps":-0.54,"name":null,"time":"","type":"earning","dateTimestamp":1573016400000,"reportTimeType":"","actualEps":-0.49}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"REXN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"REXN\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/REXN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"REXN","date":"2020-11-05","current":-0.289446,"percent":0.390029,"low":-4.027271,"twenty":-1.507351,"median":-1.05016,"eighty":-0.72395,"high":-0.496988,"avg":-1.247615,"sd":0.758405,"marketCap":8278525},"quantilePoints":[],"updateTime":1771946148707},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.rexahn.com","stockEarnings":[{"period":"1week","weight":-0.75},{"period":"1month","weight":-0.75},{"period":"3month","weight":-0.75},{"period":"6month","weight":-0.75},{"period":"1year","weight":-0.75},{"period":"ytd","weight":-0.75}],"compareEarnings":[{"period":"1week","weight":0.0009},{"period":"1month","weight":-0.0099},{"period":"3month","weight":0.0109},{"period":"6month","weight":0.0553},{"period":"1year","weight":0.1374},{"period":"ytd","weight":0.0007}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of cancer. The company's product pipeline include RX-3117, which is in Phase IIa clinical trials for the treatment of patients with relapsed or refractory metastatic pancreatic cancer, as well as bladder, colon, lung and cervical cancer. It is also developing RX-0301, which is in preclinical development stage for the treatment of hepatocellular carcinoma. Rexahn Pharmaceuticals, Inc. has collaboration agreements with Zhejiang Haichang Biotechnology Co., Ltd.; and BioSense Global LLC. The company is headquartered in Rockville, Maryland.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.070249},{"month":2,"riseRate":0.5625,"avgChangeRate":0.082556},{"month":3,"riseRate":0.375,"avgChangeRate":0.049562},{"month":4,"riseRate":0.4,"avgChangeRate":-0.004824},{"month":5,"riseRate":0.5625,"avgChangeRate":0.089659},{"month":6,"riseRate":0.375,"avgChangeRate":-0.02781},{"month":7,"riseRate":0.375,"avgChangeRate":-0.008306},{"month":8,"riseRate":0.3125,"avgChangeRate":-0.019269},{"month":9,"riseRate":0.4375,"avgChangeRate":-0.024914},{"month":10,"riseRate":0.25,"avgChangeRate":-0.113932},{"month":11,"riseRate":0.25,"avgChangeRate":-0.092341},{"month":12,"riseRate":0.4375,"avgChangeRate":0.064933}],"exchange":"NASDAQ","name":"Rexahn Pharmaceuticals","nameEN":"Rexahn Pharmaceuticals"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"REXN\",market:\"US\",,,undefined,":null}}